PDB Short entry for 2OJ9 HEADER TRANSFERASE 12-JAN-07 2OJ9 TITLE STRUCTURE OF IGF-1R KINASE DOMAIN COMPLEXED WITH A BENZIMIDAZOLE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR PRECURSOR (EC COMPND 3 2.7.10.1) (INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (IGF-I RECEPTOR) COMPND 4 (CD221 ANTIGEN); COMPND 5 CHAIN: A; COMPND 6 FRAGMENT: KINASE DOMAIN, RESIDUES 982-1286; COMPND 7 SYNONYM: CD221 ANTIGEN, IGF1R; COMPND 8 EC: 2.7.1.112; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IGF1R; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS HORMONE/GROWTH FACTOR, IGF-1R, KINASE DOMAIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.S.SACK,B.L.JACOBSON REVDAT 3 27-DEC-23 2OJ9 1 REMARK SEQADV REVDAT 2 24-FEB-09 2OJ9 1 VERSN REVDAT 1 01-MAY-07 2OJ9 0 JRNL AUTH U.VELAPARTHI,M.WITTMAN,P.LIU,K.STOFFAN,K.ZIMMERMANN,X.SANG, JRNL AUTH 2 J.CARBONI,A.LI,R.ATTAR,M.GOTTARDIS,A.GREER,C.Y.CHANG, JRNL AUTH 3 B.L.JACOBSEN,J.S.SACK,Y.SUN,D.R.LANGLEY,B.BALASUBRAMANIAN, JRNL AUTH 4 D.VYAS JRNL TITL DISCOVERY AND INITIAL SAR OF JRNL TITL 2 3-(1H-BENZO[D]IMIDAZOL-2-YL)PYRIDIN-2(1H)-ONES AS INHIBITORS JRNL TITL 3 OF INSULIN-LIKE GROWTH FACTOR 1-RECEPTOR (IGF-1R). JRNL REF BIOORG.MED.CHEM.LETT. V. 17 2317 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17317169 JRNL DOI 10.1016/J.BMCL.2007.01.102 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 1.9.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 13.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 21499 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1096 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.12 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.70 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3019 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 20.350 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2862 REMARK 3 BIN R VALUE (WORKING SET) : 0.1998 REMARK 3 BIN FREE R VALUE : 0.2726 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 157 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2358 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 204 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.06 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.72593 REMARK 3 B22 (A**2) : -0.98521 REMARK 3 B33 (A**2) : -0.74072 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -5.69129 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2441 ; 2.000 ; NULL REMARK 3 BOND ANGLES : 3280 ; 2.000 ; NULL REMARK 3 TORSION ANGLES : 547 ; 0.000 ; NULL REMARK 3 TRIGONAL CARBON PLANES : 72 ; 2.000 ; NULL REMARK 3 GENERAL PLANES : 351 ; 5.000 ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : 2437 ; 20.000 ; NULL REMARK 3 BAD NON-BONDED CONTACTS : 97 ; 5.000 ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2OJ9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000041204. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54180 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21556 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.24000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.14450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 1 CHAIN(S). AUTHORS STATE THAT A MONOMER REMARK 300 IS THE BIOLOGICAL UNIT OF THIS POLYPEPTIDE. SEE REMARK 350 REMARK 300 FOR INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 950 REMARK 465 VAL A 951 REMARK 465 SER A 952 REMARK 465 ALA A 953 REMARK 465 MET A 1068 REMARK 465 GLU A 1069 REMARK 465 ASN A 1070 REMARK 465 ASN A 1071 REMARK 465 PRO A 1072 REMARK 465 VAL A 1073 REMARK 465 LEU A 1074 REMARK 465 ALA A 1075 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A1067 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 959 C - N - CA ANGL. DEV. = 18.1 DEGREES REMARK 500 PRO A 959 C - N - CD ANGL. DEV. = -20.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 955 36.45 -73.60 REMARK 500 VAL A 956 106.23 -35.12 REMARK 500 TYR A 957 -135.98 -112.79 REMARK 500 VAL A 958 74.92 -112.16 REMARK 500 PRO A 959 -47.79 -13.76 REMARK 500 ASP A 960 178.23 39.30 REMARK 500 LYS A 993 -63.44 -28.59 REMARK 500 ALA A1009 134.92 -178.48 REMARK 500 ARG A1104 -12.60 78.05 REMARK 500 ASP A1105 41.94 -143.01 REMARK 500 MET A1126 -33.39 70.41 REMARK 500 TYR A1131 61.88 -118.16 REMARK 500 LYS A1141 54.24 37.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BMI A 301 DBREF 2OJ9 A 952 1256 UNP P08069 IGF1R_HUMAN 982 1286 SEQADV 2OJ9 MET A 950 UNP P08069 CLONING ARTIFACT SEQADV 2OJ9 VAL A 951 UNP P08069 CLONING ARTIFACT SEQRES 1 A 307 MET VAL SER ALA ALA ASP VAL TYR VAL PRO ASP GLU TRP SEQRES 2 A 307 GLU VAL ALA ARG GLU LYS ILE THR MET SER ARG GLU LEU SEQRES 3 A 307 GLY GLN GLY SER PHE GLY MET VAL TYR GLU GLY VAL ALA SEQRES 4 A 307 LYS GLY VAL VAL LYS ASP GLU PRO GLU THR ARG VAL ALA SEQRES 5 A 307 ILE LYS THR VAL ASN GLU ALA ALA SER MET ARG GLU ARG SEQRES 6 A 307 ILE GLU PHE LEU ASN GLU ALA SER VAL MET LYS GLU PHE SEQRES 7 A 307 ASN CYS HIS HIS VAL VAL ARG LEU LEU GLY VAL VAL SER SEQRES 8 A 307 GLN GLY GLN PRO THR LEU VAL ILE MET GLU LEU MET THR SEQRES 9 A 307 ARG GLY ASP LEU LYS SER TYR LEU ARG SER LEU ARG PRO SEQRES 10 A 307 GLU MET GLU ASN ASN PRO VAL LEU ALA PRO PRO SER LEU SEQRES 11 A 307 SER LYS MET ILE GLN MET ALA GLY GLU ILE ALA ASP GLY SEQRES 12 A 307 MET ALA TYR LEU ASN ALA ASN LYS PHE VAL HIS ARG ASP SEQRES 13 A 307 LEU ALA ALA ARG ASN CYS MET VAL ALA GLU ASP PHE THR SEQRES 14 A 307 VAL LYS ILE GLY ASP PHE GLY MET THR ARG ASP ILE TYR SEQRES 15 A 307 GLU THR ASP TYR TYR ARG LYS GLY GLY LYS GLY LEU LEU SEQRES 16 A 307 PRO VAL ARG TRP MET SER PRO GLU SER LEU LYS ASP GLY SEQRES 17 A 307 VAL PHE THR THR TYR SER ASP VAL TRP SER PHE GLY VAL SEQRES 18 A 307 VAL LEU TRP GLU ILE ALA THR LEU ALA GLU GLN PRO TYR SEQRES 19 A 307 GLN GLY LEU SER ASN GLU GLN VAL LEU ARG PHE VAL MET SEQRES 20 A 307 GLU GLY GLY LEU LEU ASP LYS PRO ASP ASN CYS PRO ASP SEQRES 21 A 307 MET LEU PHE GLU LEU MET ARG MET CYS TRP GLN TYR ASN SEQRES 22 A 307 PRO LYS MET ARG PRO SER PHE LEU GLU ILE ILE SER SER SEQRES 23 A 307 ILE LYS GLU GLU MET GLU PRO GLY PHE ARG GLU VAL SER SEQRES 24 A 307 PHE TYR TYR SER GLU GLU ASN LYS HET BMI A 301 30 HETNAM BMI 3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]- HETNAM 2 BMI 4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE FORMUL 2 BMI C22 H19 N7 O FORMUL 3 HOH *204(H2 O) HELIX 1 1 ALA A 965 GLU A 967 5 3 HELIX 2 2 SER A 1010 SER A 1022 1 13 HELIX 3 3 VAL A 1023 PHE A 1027 5 5 HELIX 4 4 ASP A 1056 SER A 1063 1 8 HELIX 5 5 SER A 1078 ASN A 1099 1 22 HELIX 6 6 ALA A 1107 ARG A 1109 5 3 HELIX 7 7 TYR A 1131 TYR A 1135 5 5 HELIX 8 8 PRO A 1145 MET A 1149 5 5 HELIX 9 9 SER A 1150 GLY A 1157 1 8 HELIX 10 10 THR A 1160 THR A 1177 1 18 HELIX 11 11 SER A 1187 GLU A 1197 1 11 HELIX 12 12 PRO A 1208 TRP A 1219 1 12 HELIX 13 13 ASN A 1222 ARG A 1226 5 5 HELIX 14 14 SER A 1228 LYS A 1237 1 10 HELIX 15 15 GLU A 1238 MET A 1240 5 3 HELIX 16 16 GLU A 1241 PRO A 1242 5 2 HELIX 17 17 GLY A 1243 SER A 1248 1 6 SHEET 1 A 5 ILE A 969 GLN A 977 0 SHEET 2 A 5 MET A 982 VAL A 992 -1 O VAL A 983 N LEU A 975 SHEET 3 A 5 GLU A 995 THR A1004 -1 O ILE A1002 N TYR A 984 SHEET 4 A 5 LEU A1046 GLU A1050 -1 O MET A1049 N ALA A1001 SHEET 5 A 5 LEU A1035 VAL A1039 -1 N LEU A1036 O ILE A1048 SHEET 1 B 2 CYS A1111 VAL A1113 0 SHEET 2 B 2 VAL A1119 ILE A1121 -1 O LYS A1120 N MET A1112 SHEET 1 C 2 TYR A1136 LYS A1138 0 SHEET 2 C 2 GLY A1142 LEU A1144 -1 O LEU A1144 N TYR A1136 CISPEP 1 GLN A 1043 PRO A 1044 0 -0.32 SITE 1 AC1 11 HOH A 112 LEU A 975 ALA A1001 MET A1049 SITE 2 AC1 11 GLU A1050 LEU A1051 MET A1052 THR A1053 SITE 3 AC1 11 GLY A1055 MET A1112 THR A1127 CRYST1 57.271 44.289 65.744 90.00 99.05 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017461 0.000000 0.002781 0.00000 SCALE2 0.000000 0.022579 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015402 0.00000